Liquid chromatography-high resolution mass spectrometry with immunoaffinity clean-up for the determination of the oxidative stress biomarker 8-iso-prostaglandin F2alpha in wastewater

Journal of Chromatography A

Volumn 1409, Issue , 2015, Pages 146-151

  Ryu, Yeonsuk ^a,b   Reid, Malcolm J ^a   Thomas, Kevin V ^a  

^a NORWEGIAN INSTITUTE FOR WATER RESEARCH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

F2 isoprostanes; Health biomarker; Immunoaffinity clean up; Liquid chromatography high resolution mass spectrometry; Oxidative stress; Wastewater based epidemiology

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; OXIDATIVE STRESS; SEWAGE; SPECTROMETRY;

BETA-GLUCURONIDASE; CORRELATION COEFFICIENT; IMMUNOAFFINITY; ISOPROSTANES; LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRIES; OXIDATIVE STRESS BIOMARKERS; QUANTIFICATION LIMIT; RELATIVE STANDARD DEVIATIONS;

LIQUID CHROMATOGRAPHY;

8 ISOPROSTAGLANDIN F2 ALPHA; BETA GLUCURONIDASE; GLUCURONIDE; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; PROSTAGLANDIN F2 ALPHA; SEWAGE; WATER POLLUTANT;

ANALYTE STABILITY; ANTIBODY AFFINITY; ARTICLE; BINDING AFFINITY; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYMATIC DECONJUGATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; OXIDATIVE STRESS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEWAGE; WASTE WATER; ANALOGS AND DERIVATIVES; ANALYSIS; CHEMISTRY; PROCEDURES; WATER POLLUTANT;

BIOMARKERS; CHROMATOGRAPHY, LIQUID; DINOPROST; GLUCURONIDASE; MASS SPECTROMETRY; OXIDATIVE STRESS; SEWAGE; WATER POLLUTANTS, CHEMICAL;

EID: 84941599087     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2015.07.060     Document Type: Article

References (42)

1. Daughton C.G. Illicit drugs in municipal sewage. Pharm Care Prod. Environ. 2001, 348-364. (American Chemical Society, accessed 18.03.15). 10.1021/bk-2001-0791.ch020.
2. Daughton C.G. Using biomarkers in sewage to monitor community-wide human health: isoprostanes as conceptual prototype. Sci. Total Environ. 2012, 424:16-38. 10.1016/j.scitotenv.2012.02.038.
3. Thomas K.V., Reid M.J. What else can the analysis of sewage for urinary biomarkers reveal about communities?. Environ. Sci. Technol. 2011, 45:7611-7612. 10.1021/es202522d.
4. Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2006, 78:8421-8429. 10.1021/ac061095b.
5. Postigo C., Lopez de Alda M.J., Barceló D. Analysis of drugs of abuse and their human metabolites in water by LC-MS2: a non-intrusive tool for drug abuse estimation at the community level. TrAC: Trends Anal. Chem. 2008, 27:1053-1069. 10.1016/j.trac.2008.10.002.
6. Zuccato E., Chiabrando C., Castiglioni S., Bagnati R., Fanelli R. Estimating community drug abuse by wastewater analysis. Environ. Health Perspect. 2008, 116:1027-1032. 10.1289/ehp.11022.
7. Reid M.J., Langford K.H., Mørland J., Thomas K.V. Analysis and interpretation of specific ethanol metabolites, ethyl sulfate, and ethyl glucuronide in sewage effluent for the quantitative measurement of regional alcohol consumption, alcohol. Clin. Exp. Res. 2011, 35:1593-1599. 10.1111/j.1530-0277.2011.01505.x.
8. van Nuijs A.L.N., Castiglioni S., Tarcomnicu I., Postigo C., de Alda M.L., Neels H., et al. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci. Total Environ. 2011, 409:3564-3577. 10.1016/j.scitotenv.2010.05.030.
9. Thomas K.V., Bijlsma L., Castiglioni S., Covaci A., Emke E., Grabic R., et al. Comparing illicit drug use in 19 European cities through sewage analysis. Sci. Total Environ. 2012, 432:432-439. 10.1016/j.scitotenv.2012.06.069.
10. Rodríguez-Álvarez T., Rodil R., Rico M., Cela R., Quintana J.B. Assessment of Local tobacco consumption by liquid chromatography-tandem mass spectrometry sewage analysis of nicotine and its metabolites, cotinine and trans-3'-hydroxycotinine, after enzymatic deconjugation. Anal. Chem. 2014, 86:10274-10281. 10.1021/ac503330c.
11. Kasprzyk-Hordern B., Baker D.R. Estimation of community-wide drugs use via stereoselective profiling of sewage. Sci. Total Environ. 2012, 423:142-150. 10.1016/j.scitotenv.2012.02.019.
12. van Nuijs A.L.N., Mougel J.-F., Tarcomnicu I., Bervoets L., Blust R., Jorens P.G., et al. Sewage epidemiology - a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium. Environ. Int. 2011, 37:612-621. 10.1016/j.envint.2010.12.006.
13. Zuccato E., Chiabrando C., Castiglioni S., Calamari D., Bagnati R., Schiarea S., et al. Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ. Health 2005, 4:14. 10.1186/1476-069X-4-14.
14. Karolak S., Nefau T., Bailly E., Solgadi A., Levi Y. Estimation of illicit drugs consumption by wastewater analysis in Paris area. Forensic Sci. Int. 2010, 200:153-160. (in France). 10.1016/j.forsciint.2010.04.007.
15. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Multi-residue method for the determination of basic/neutral pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J. Chromatogr. A 2007, 1161:132-145. 10.1016/j.chroma.2007.05.074.
16. Baker D.R., Barron L., Kasprzyk-Hordern B. Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part A: chemical analysis and drug use estimates. Sci. Total Environ. 2014, 487:629-641. 10.1016/j.scitotenv.2013.11.107.
17. Rodríguez-Álvarez T., Rodil R., Cela R., Quintana J.B. Ion-pair reversed-phase liquid chromatography-quadrupole-time-of-flight and triple-quadrupole-mass spectrometry determination of ethyl sulfate in wastewater for alcohol consumption tracing. J. Chromatogr. A 2014, 1328:35-42. 10.1016/j.chroma.2013.12.076.
18. Mastroianni N., Lopez de Alda M., Barcelo D. Analysis of ethyl sulfate in raw wastewater for estimation of alcohol consumption and its correlation with drugs of abuse in the city of Barcelona. J. Chromatogr. A 2014, 1360:93-99. 10.1016/j.chroma.2014.07.051.
19. Castiglioni S., Senta I., Borsotti A., Davoli E., Zuccato E. A novel approach for monitoring tobacco use in local communities by wastewater analysis. Tob. Control 2015, 24:38-42. 10.1136/tobaccocontrol-2014-051553.
20. Giustarini D., Dalle-Donne I., Tsikas D., Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit. Rev. Clin. Lab. Sci. 2009, 46:241-281. 10.3109/10408360903142326.
21. Montuschi P., Barnes P., Jackson Roberts L. Insights into oxidative stress: the isoprostanes. Curr. Med. Chem. 2007, 14:703-717. 10.2174/092986707780059607.
22. Basu S. The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target. Scand. J. Food Nutr. 2007, 51:48-61. 10.1080/17482970701411642.
23. Milne G.L., Musiek E.S., Morrow J.D. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005, 10:10-23. 10.1080/13547500500216546.
24. Wood L.G., Gibson P.G., Garg M.L. A review of the methodology for assessing in vivo antioxidant capacity. J. Sci. Food Agric. 2006, 86:2057-2066. 10.1002/jsfa.2604.
25. Milne G.L., Sanchez S.C., Musiek E.S., Morrow J.D. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc. 2007, 2:221-226. 10.1038/nprot.2006.375.
26. Patrono C., FitzGerald G.A. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2309-2315. 10.1161/01.ATV.17.11.2309.
27. Montuschi P., Barnes P.J., Roberts L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004, 18:1791-1800. 10.1096/fj.04-2330rev.
28. Cracowski J.-L., Durand T., Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol. Sci. 2002, 23:360-366. 10.1016/S0165-6147(02)02053-9.
29. Proudfoot J., Barden A., Mori T.A., Burke V., Croft K.D., Beilin L.J., et al. Measurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation - a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal. Biochem. 1999, 272:209-215. 10.1006/abio.1999.4187.
30. Berdeaux O., Scruel O., Cracowski J.L., Durand T. F2-isoprostanes: review of analytical methods. Curr. Pharm. Anal. 2006, 2:69-78.
31. Kortz L., Dorow J., Ceglarek U. Liquid chromatography-tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: a review. J. Chromatogr. B 2014, 964:1-11. 10.1016/j.jchromb.2014.01.046.
32. Klawitter J., Haschke M., Shokati T., Klawitter J., Christians U. Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared. Rapid Commun. Mass Spectrom. 2011, 25:463-468. 10.1002/rcm.4871.
33. Yan Z., Mas E., Mori T.A., Croft K.D., Barden A.E. A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates. Anal. Biochem. 2010, 403:126-128. 10.1016/j.ab.2010.04.016.
34. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ. Sci. Technol. 2010, 44:6024-6035. 10.1021/es100779n.
35. Medina S., Domínguez-Perles R., Gil J.I., Ferreres F., García-Viguera C., Martínez-Sanz J.M., et al. A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet. Rapid Commun. Mass Spectrom. 2012, 26:1249-1257. 10.1002/rcm.6224.
36. Medina S., Domínguez-Perles R., Cejuela-Anta R., Villaño D., Martínez-Sanz J.M., Gil P., et al. Assessment of oxidative stress markers and prostaglandins after chronic training of triathletes. Prostaglandins Other Lipid Mediat. 2012, 99:79-86. 10.1016/j.prostaglandins.2012.07.002.
37. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030. 10.1021/ac020361s.
38. Yu K., Li B., Zhang T. Direct rapid analysis of multiple PPCPs in municipal wastewater using ultrahigh performance liquid chromatography-tandem mass spectrometry without SPE pre-concentration. Anal. Chim. Acta 2012, 738:59-68. 10.1016/j.aca.2012.05.057.
39. Migowska N., Caban M., Stepnowski P., Kumirska J. Simultaneous analysis of non-steroidal anti-inflammatory drugs and estrogenic hormones in water and wastewater samples using gas chromatography-mass spectrometry and gas chromatography with electron capture detection. Sci. Total Environ. 2012, 441:77-88. 10.1016/j.scitotenv.2012.09.043.
40. Langhorst M.L., Hastings M.J., Yokoyama W.H., Hung S.-C., Cellar N., Kuppannan K., et al. Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry. J. Agric. Food Chem. 2010, 58:6614-6620. 10.1021/jf101146q.
41. Plumb R.S., Johnson K.A., Rainville P., Smith B.W., Wilson I.D., Castro-Perez J.M., et al. UPLC/MSE; a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun. Mass Spectrom. 2006, 20:1989-1994. 10.1002/rcm.2550.
42. D. Tsikas, M.-T. Suchy, Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography, J. Chromatogr. B. (n.d.). doi:10.1016/j.jchromb.2014.12.019.